| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 126006-86-8 | 1,3,4-Oxadiazol-2-amine,5-[([1,1'-biphenyl]-4-yloxy)methyl]-N-(3,4-dimethylphenyl)- |  | C23H21N3O2 | 詳情 | 供應商 | |
| 29530-03-8 | 1,3,5-Triazine-2,4(1H,3H)-dithione,6-(ethylamino)-; s-Triazine-2,4-dithiol,6-(ethylamino)- (8CI) |  | C5H8N4S2 | 詳情 | 供應商 | |
| 95634-82-5 | 11H-[1,2,4]Triazolo[1,5-c][1,3]benzodiazepine,2-methyl-5-(4-methyl-1-piperazinyl)-; Batelapine; CGS 13429 |  | C16H20N6 | 詳情 | 供應商 | |
| 496-13-9 | 1H-Pyrrolo[3,4-c]pyridine,2,3-dihydro-; 2,3-Dihydro-1H-pyrrolo[3,4-c]pyridine; Merimine |  | C7H8N2 | 詳情 | 供應商 | |
| 24994-55-6 | 1H-Benzimidazol-6-ol,5,7-dichloro-2-(trifluoromethyl)-; 1H-Benzimidazol-5-ol,4,6-dichloro-2-(trifluoromethyl)- (9CI); 5-Benzimidazolol, 4,6-dichloro-2-(trifluoromethyl)-(8CI); 4,6-Dichloro-5-hydroxy-2-trifluoromethylbenzimidazole |  | C8H3Cl2F3N2O | 詳情 | 供應商 | |
| 29278-78-2 | 1-Butanaminium,N,N-diethyl-4-[(3-methoxybenzoyl)oxy]-N-methyl-, bromide (1:1); Ammonium,diethyl(4-hydroxybutyl)methyl-, bromide, m-anisate (8CI); m-Anisic acid, esterwith diethyl(4-hydroxybutyl)methylammonium bromide (8CI) |  | C26H51BrN2O5 | 詳情 | 供應商 | |
| 37552-33-3 | 1-8-Vasopressin,8-L-arginine-; Vasopressin,8-L-arginine-9-deglycinamide-; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv.; (Arg8,des-Gly-NH29)-vasopressin; 8-Arginine-9-deglycinamide-vasopressin; 8-Arginine-9-desglycinamidevasopressin; Arginine vasopressin-(1-8); Org 5667; [Arg8,de-Gly9]-vasopressin; [Deglycinamide9,arginine8]-vasopressin; [Desglycinamide9-arginine8]-vasopressin |  | C44H61N13O12S2 | 詳情 | 供應商 | |
| 70851-49-9 | 1,3,6,9,12-Pentaoxa-2-silacyclotetradecane,2,2-dimethyl-; Dimethylsila-14-crown-5 |  | C10H22O5Si | 詳情 | 供應商 | |
| 104907-90-6 | 1H-Pyrazole-4-carboxylicacid, 5-(2-methyl-4-oxo-3(4H)-quinazolinyl)-1-phenyl-, ethyl ester |  | C21H18N4O3 | 詳情 | 供應商 | |
| 24269-89-4 | 1-Piperazinecarboxylicacid, 4-[2-(pentylamino)ethyl]-, cyclohexyl ester, hydrochloride (1:1); 1-Piperazinecarboxylicacid, 4-[2-(pentylamino)ethyl]-, cyclohexyl ester, monohydrochloride (8CI) |  | C18H36ClN3O2 | 詳情 | 供應商 | |
| 59343-64-5 | 1H-1,2,3-Triazole-4-carboxamide,5-hydroxy-1-b-D-ribofuranosyl-; 5-hydroxy-1-(beta-D-ribofuranosyl)-1,2,3-triazole-4-carboxamide |  | C8H12N4O6 | 詳情 | 供應商 | |
| 53786-46-2 | 1-Piperidinecarboxylicacid, 4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-, ethyl ester; ethyl 4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidine-1-carboxylate; ETHYL 4-(5-CHLORO-2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-2-YL)PIPERIDINE-1-CARBOXYLATE |  | C15H18ClN3O3 | 詳情 | 供應商 | |
| 101976-28-7 | 10H-Phenothiazine,2-chloro-10-(2-chloropropyl)- |  | C15H13Cl2NS | 詳情 | 供應商 | |
| 53894-23-8 | 1,2,4-Benzenetricarboxylicacid, 1,2,4-triisononyl ester; 1,2,4-Benzenetricarboxylicacid, triisononyl ester (9CI); ADK Cizer C 9N; Adeka C 9N; Jayflex TINTM; Triisononyltrimellitate |  | C36H60O6 | 詳情 | 供應商 | |
| 100706-81-8 | 1H-Purine-2,6-dione,3,7-dihydro-1,3-dimethyl-7-[2-(4-morpholinyl)-2-oxoethyl]-; Morpholine,4-[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]- (9CI); Morpholine, 4-[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]-(6CI); Teomorfolin |  | C13H17N5O4 | 詳情 | 供應商 | |
| 53786-42-8 | 1-Piperidinecarboxylicacid, 4-(hydroxyimino)-, ethyl ester; Ethyl4-hydroxyimino-1-piperidinecarboxylate |  | C8H14N2O3 | 詳情 | 供應商 | |
| 85348-46-5 | 1-Pyrrolidineacetamide,3-hydroxy-2-oxo-, (S)- (9CI); 2-[(3S)-3-hydroxy-2-oxo-pyrrolidin-1-yl]acetamide |  | C6H10N2O3 | 詳情 | 供應商 | |
| 18988-74-4 | 1,2-Dicarbadodecaborane(12),3,4,5,6,7,8,9,10,11,12-decachloro- (7CI,8CI,9CI); B-Decachloro-o-barene; B-Decachloro-o-carborane; Decachloro-o-carborane |  | C2H2B10Cl10 | 詳情 | 供應商 | |
| 13245-55-1 | 1,4-Benzenediol,1-(4-nitrobenzoate); 1,4-Benzenediol,mono(4-nitrobenzoate) (9CI); Hydroquinone, mono(p-nitrobenzoate) (8CI); Hydroquinone, p-nitrobenzoate (7CI); 4-Hydroxyphenyl 4-nitrobenzoate; NSC 23422 |  | C13H9NO5 | 詳情 | 供應商 | |
| 17411-19-7 | 1H-Pyrido[4,3-b]indole,2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-; Dicarbine |  | C13H18N2 | 詳情 | 供應商 | |